✦ LIBER ✦

Thyroid Outcome During Long-Term Gonadotropin-Releasing Hormone Agonist Treatments for Idiopathic Precocious Puberty

✍ Scribed by Francesco Massart; Joshua Chuck Harrell; Giovanni Federico; Giuseppe Saggese

Book ID: 116593234
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 281 KB
Volume: 40
Category: Article
ISSN: 1054-139X
DOI: 10.1016/j.jadohealth.2006.09.024

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Do all girls with apparent idiopathic pr

Do all girls with apparent idiopathic precocious puberty require gonadotropin-releasing hormone agonist treatment?

✍ Juliane Léger; Rachel Reynaud; Paul Czernichow 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 90 KB

Slipped capital femoral epiphysis during

Slipped capital femoral epiphysis during the treatment of precocious puberty with a gonadotropin-releasing hormone-agonist: aetiological considerations

✍ Fumiko Yamato; Junji Takaya; Hirohiko Higashino; Yasuo Yamanouchi; Hiroshi Sueha 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 170 KB

Central precocious puberty in girls: Int

Central precocious puberty in girls: Internal genitalia before, during, and after treatment with long-acting gonadotropin-releasing hormone analogues

✍ Anne-Mette Bæk Jensen; Vibeke Brocks; Kirsten Holm; Eva M. Laursen; Jørn Müller 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 268 KB

Insight: Prolonged Vaginal Bleeding duri

Insight: Prolonged Vaginal Bleeding during Central Precocious Puberty Therapy with a Long-acting Gonadotropin-Releasing Hormone Agonist: A Proposed Mechanism and Management Plan

✍ Arieh Kauschansky; Raoul Orvieto; Arie Yeshaya; Boris Shterntal; Zvi Naor 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Changes in bone mineral density and body

Changes in bone mineral density and body composition during initial and long-term gonadotropin-releasing hormone agonist treatment for prostate carcinoma

✍ Hang Lee; Katelyn McGovern; Joel S. Finkelstein; Matthew R. Smith 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 1 views

## Abstract ## BACKGROUND Initial treatment with a gonadotropin‐releasing hormone (GnRH) agonist increases fat mass, decreases lean body mass, and decreases bone mineral density (BMD) in men with prostate carcinoma. To the authors' knowledge, little is known regarding either the long‐term effects

Long-term administration of tibolone plu

Long-term administration of tibolone plus gonadotropin-releasing hormone agonist for the treatment of uterine leiomyomas: effectiveness and effects on vasomotor symptoms, bone mass, and lipid profiles

✍ Stefano Palomba; Pietro Affinito; Costantino Di Carlo; Giuseppe Bifulco; Carmine 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 177 KB